+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Investigation Report on China's Nicergoline Market 2021-2025

  • PDF Icon

    Report

  • 50 Pages
  • July 2021
  • Region: China
  • China Research & Intelligence
  • ID: 5393430
Nicergoline is a kind of ergot derivative, used to treat Alzheimer's disease and other vascular diseases, originally researched by Pfizer Pharmaceuticals. Since its successful development in the 1960s, it has been registered and used in more than 50 countries. By 2020, Nicergoline has been included in China's Class B medical insurance, and there are already several manufacturers in the Chinese market, among which Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd. has the most market share.





According to the analyst's market research, the sales value of Nicergoline in the Chinese market has increased year by year from 2016 to 2020. Among them, the growth in 2019 was the most obvious. The sales value of Nicergoline increased from CNY138 million in 2018 to CNY190 million in 2019, with an annual growth rate of 37.57%. In 2020, the sales value of Nicergoline in the Chinese market is CNY237 million, and the CAGR from 2016 to 2020 is 16.6%.

The analyst expects that with the increase in the number of patients with Alzheimer's disease, the sales value of Nicergoline in the Chinese market will continue to grow from 2021 to 2025. By 2020, the incidence of Alzheimer’s disease in the elderly over 65 years old in China was 4%-6%, and the aging degree in China will continue to increase in the future, which will cause the number of patients with Alzheimer’s disease to continue to increase. Therefore, sales volume and sales value in Nicergoline will also continue to increase.

Topics Covered:

  • The impact of COVID-19 on China's Nicergoline market
  • Sales value of China's Nicergoline 2016-2020
  • Competitive landscape of China's Nicergoline market
  • Prices of Nicergoline in China
  • Prices of Nicergoline in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Nicergoline market
  • Prospect of China's Nicergoline market from 2021 to 2025
Frequently Asked Questions about the Chinese Nicergoline Market

What is the estimated value of the Chinese Nicergoline Market?

The Chinese Nicergoline Market was estimated to be valued at CNY 128.09 Million in 2016.

What is the growth rate of the Chinese Nicergoline Market?

The growth rate of the Chinese Nicergoline Market is 15.7%, with an estimated value of CNY 475.97 Million by 2025.

What is the forecasted size of the Chinese Nicergoline Market?

The Chinese Nicergoline Market is estimated to be worth CNY 475.97 Million by 2025.

Who are the key companies in the Chinese Nicergoline Market?

Key companies in the Chinese Nicergoline Market include Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd. (Lexilin), Hainan General Kangli Pharmaceutical Co., Ltd. (Hainan Puli), Pfizer Pharmaceuticals Co., Ltd. (SERMION) and Hainan general Sanyo Pharmaceutical Co., Ltd. (Kaier).

Table of Contents

1 Relevant Concepts of Nicergoline
1.1 Indications for Nicergoline
1.2 Development of Nicergoline in China
1.3 Governmental Approval of Nicergoline in China
1.4 The Impact of COVID-19 on Nicergoline sales in China
2 Sales of Nicergoline in China, 2016-2020
2.1 Sales Value of Nicergoline
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Nicergoline
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Nicergoline by Dosage Form in China, 2016-2020
2.3.1 Tablets
2.3.3 Injection
2.3.3 Capsules
3 Analysis of Major Nicergoline Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Nicergoline Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Lexilin (Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd.’s Nicergoline) in China
3.3 Hainan General Kangli Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Hainan Puli (Hainan General Kangli Pharmaceutical Co., Ltd. ’s Nicergoline) in China
3.4 Pfizer Pharmaceuticals Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of SERMION (Pfizer Pharmaceuticals Co., Ltd.’s Nicergoline) in China
3.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Fulutong (Chengdu Tiantaishan Pharmaceutical Co., Ltd.’s Nicergoline) in China
3.6 Hainan general Sanyo Pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Kaier (Hainan general Sanyo Pharmaceutical Co., Ltd.’s Nicergoline) in China
4 Prices of Nicergoline for Different Manufacturers in China, 2020-2021
4.1 Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd. (Lexilin)
4.2 Hainan General Kangli Pharmaceutical Co., Ltd. (Hainan Puli)
4.3 Pfizer Pharmaceuticals Co., Ltd. (SERMION)
4.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. (Fulutong)
4.5 Hainan general Sanyo Pharmaceutical Co., Ltd. (Kaier)
5 Prospect of Chinese Nicergoline Market, 2021-2025
5.1 Influential Factors of Chinese Nicergoline Market Development
5.1.1 The Impact of COVID-19 on Chinese Nicergoline Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Nicergoline Tablets Registration in China
Chart Patent Information About Nicergoline Injection Registration in China
Chart Patent Information About Nicergoline Capsules Registration in China
Chart Sales Value of Nicergoline Tablets over the World
Chart Sales Value of Nicergoline Injection over the World
Chart Sales Value of Nicergoline Capsules over the World
Chart Sales Value of Nicergoline Tablets in China, 2016-2020
Chart Sales Value of Nicergoline Injection in China, 2016-2020
Chart Sales Value of Nicergoline Capsules in China, 2016-2020
Chart Sales Value of Nicergoline Tablets in China by Region, 2016-2020
Chart Sales Value of Nicergoline Injection in China by Region, 2016-2020
Chart Sales Value of Nicergoline Capsules in China by Region, 2016-2020
Chart Sales Volume of Nicergoline Tablets in China, 2016-2020
Chart Sales Volume of Nicergoline Injection in China, 2016-2020
Chart Sales Volume of Nicergoline Capsules in China, 2016-2020
Chart Sales Volume of Nicergoline Tablets in China by Region, 2016-2020
Chart Sales Volume of Nicergoline Injection in China by Region, 2016-2020
Chart Sales Volume of Nicergoline Capsules in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Nicergoline Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Nicergoline Injection Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Nicergoline Capsules Manufacturers in China, 2016-2020
Chart Sales Value and Volume of Lexilin in China, 2016-2020
Chart Sales Value and Volume of Hainan Puli in China, 2016-2020
Chart Sales Value and Volume of SERMION in China, 2016-2020
Chart Sales Value and Volume of Fulutong in China, 2016-2020
Chart Sales Value and Volume of Kaier in China, 2016-2020
Chart Referential Prices of Lexilin in China by Region, 2020-2021
Chart Referential Prices of Hainan Puli in China by Region, 2020-2021
Chart Referential Prices of SERMION in China by Region, 2020-2021
Chart Referential Prices of Fulutong in China by Region, 2020-2021
Chart Referential Prices of Kaier in China by Region, 2020-2021
Chart Forecast on Sales Value of Nicergoline Tablets in China, 2021-2025
Chart Forecast on Sales Value of Nicergoline Injection in China, 2021-2025
Chart Forecast on Sales Value of Nicergoline Capsules in China, 2021-2025
Chart Forecast on Sales Volume of Nicergoline Tablets in China, 2021-2025
Chart Forecast on Sales Volume of Nicergoline Injection in China, 2021-2025
Chart Forecast on Sales Volume of Nicergoline Capsules in China, 2021-2025

Samples

Loading
LOADING...

Companies Mentioned

  • Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd. (Lexilin)
  • Hainan General Kangli Pharmaceutical Co., Ltd. (Hainan Puli)
  • Pfizer Pharmaceuticals Co., Ltd. (SERMION)
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd. (Fulutong)
  • Hainan general Sanyo Pharmaceutical Co., Ltd. (Kaier)

Methodology

Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.

Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.

Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.

The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.

The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.

1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.


 

Loading
LOADING...